Terry Hennessey Microbiology Fellowship
About the Terry Hennessey* Microbiology Fellowship: The Terry Hennessey Microbiology Fellowship offers a young investigator (normally under the age of 35) working in the field of infectious diseases, a travel grant of up to £1,500 to present a paper/poster at the annual ASM Microbe Meeting in the USA.
Eligibility: This Fellowship is open to applicants on a worldwide basis and the BSAC administers this award on behalf of the Terry Hennessey Microbiology Fellowship Trust. Applications are considered by the BSAC Grants Secretary.
Value of the Award: Maximum of £1,500 (payable to the applicant upon return from ASM Microbe conference and submission of all expense receipts and a full written report).
Terms and Conditions: This award is up to a value of £1,500. The Terms and Conditions for all BSAC Grants and Scholarships are published on the BSAC website. The applicant and host institute is required to read the terms and conditions before completing any application form. Applicants are required to submit a signed copy of the BSAC Terms and Conditions form, submitting this with their application form.
How to Apply: Applicants must complete the application form at the top of this page. The application form must not be altered in any way.
Applicants must submit information as follows:
- A completed application form
- A copy of the abstract submitted to the Scientific Committee for ASM Microbe
- A copy of the letter of acceptance from the Scientific Committee for ASM Microbe
- A brief curriculum vitae (maximum x2 A4 pages, including any recent publications)
- Applicants must submit a signed copy of the BSAC Terms and Conditions form (before making an application, applicants are advised to read all Terms and Conditions and Standard Operating Procedures found at: BSAC T&Cs/SOPS)
- All documents must be submitted via email to: firstname.lastname@example.org
Application Deadline: 10 April 2020 at 23:59 GMT/UK time. [ASM Microbe 2020 to be held from 18-22 June 2020 in Chicago, USA].
Payment / Claiming Funds: All original receipts should be submitted with a BSAC expenses claim form (found at the top of this page). Claim forms and receipts must be sent to: The Grants Secretary, The BSAC, 53 Regent Place, Birmingham, B1 3NJ, United Kingdom. Please obtain VAT receipts wherever possible. For any payment enquiries contact Debbie Irwin at: email@example.com
Written Reports♦: Successful applicants are required to submit a written report post attendance at ASM Microbe, and using to the BSAC Report Form at the top of this page. The report must include: 1) brief details of your professional background, 2) details of sessions attended at the conference (including benefits derived & contributing to your role/career), and 3) a copy of the abstract presented at ASM Microbe. The Report Form should be submitted to BSAC Grants via email at: firstname.lastname@example.org
♦ The Terry Hennessey Trust kindly asks that reports are written in lay terms for the benefit of Trust Sponsors who may not be scientifically or medically qualified.
Correspondence: All correspondence, including submission of final reports, should be sent via email to: email@example.com
*A Short Note About Dr Terry Hennessey: Terry Hennessey qualified in Medicine at Oxford University where he was awarded a Doctor of Medicine for his research on antibiotic-resistant on enterobacteria (undertaken with Dr Naomi Datta at the Royal Postgraduate Medical School). Keenly aware of the need to consider the serious threat posed by drug-resistant infections, Terry joined Imperial Chemical Industries Pharmaceuticals (now part of AstraZeneca) where he initiated a wide range of in vitro and in vivo tests needed for the discovery and development of novel antibacterial agents. With his medical background, scientific excellence and natural authority Terry had a wide international network. Ever a Francophile, Terry’s team included a highly professional group of chemists at ICI’s research laboratory in Reims. Notable among Terry’s achievements at ICI was the development of chlorhexidine as ‘Corsodyl’ in dental hygiene, and the novel broad-spectrum β-lactam meropenem (originally developed by Dainippon Sumitomo Pharma Co. Ltd.).
The BSAC would like to thank Jan Hennessey & Dr Trevor Franklin (formerly head of Bioscience at ICI) for this account of Terry’s contribution to the field of Antimicrobial Agents.